Manage Your Liver
Q:

A deadly liver disease is on the rise - NASH

A deadly liver disease is on the rise - NASH
A:

NASH (Nonalcoholic Steatohepatitis) is closely linked with NAFLD (Non-alcoholic fatty liver disease). Both of these liver diseases are common, and are often known as silent liver killers. NASH resembles alcoholic liver disease, but occurs in people who drink little or no alcohol at all. The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1]

 

No medication treatment, but there is a great hope

NASH affects 2 to 5 percent of Americans. An additional 10 to 20 percent of Americans have fat in their liver, but no inflammation or liver damage; this condition is called “fatty liver.” Although having some fat in the liver is normal, some people might develop inflammation because of this fat accumulation, this is when it turns into NASH. The reason behind this is still unknown, moreover, there is yet to be an official medicine for NASH, or NASH with cirrhosis. [2]

 

Despite that, YHK Therapy, a formulated compound made from natural ingredients has shown that damaged liver cells can be repaired, and liver damage caused by NASH can be treated. The promising signs shown by the method of preventing liver cell damage have lead pharmaceutical companies to start researching on and developing drugs that have similar function as YHK Therapy. 

 

What is killing the liver?

The death of liver cells and ongoing inflammation is the main cause of many liver diseases. Usually, liver cells are killed by one of two major mechanisms: apoptosis, a form of programmed cell death, or necrosis, which is uncontrolled cell death caused by infection, toxins or trauma. Both of these mechanisms can produce a state of acute and/or chronic inflammation. 

 

Check your ALT

The main marker to determine the degree of liver cell death is the ALT enzyme level, which is tested in liver function tests. ALT is an enzyme that is produced in liver cells and is naturally contained in the liver of healthy individuals. However, in liver disease patients, liver cells are damaged and as a result, ALT is released into the blood, increasing ALT levels to above the normal range. To monitor a patient's liver condition, ALT level is an important clinical biochemical marker of the severity of liver inflammation and the extent of liver disease. [3]

 

Normalise ALT level in days with YHK

ALT is the primary marker for all liver diseases including NASH. Patients with NASH often have high ALT levels, ranging from around 100 to as high as 1000. Normal ALT level should be around 45 to 50, the lower the better. If your ALT level is around the 20-30 range, then you have great liver health.

 

A pilot clinical study of YHK shows that YHK can lower patients’ ALT level within days, and all subjects’ ALT levels were brought back to normal level (under 40) after using YHK for 30 days. No side effect was observed during the use of the natural therapy.

 

If you are currently experiencing NASH, with or without cirrhosis, you are welcome to send us any questions or contact our support team for further information about YHK.

 

The above YHK study was conducted in a university in Canada by PAUL MAROTTA, MD and was later published in the medical journal Digestive Diseases and Sciences 2006 and is currently listed on PubMed.gov. [4]

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
Being the most serious form of liver disease, liver cancer is on the rise globally. While we have always known that liver cancer doesn’t develop overnight, there have not been many studies that investigate the potential risks for liver cancer for patients with liver diseases. According to a recent research conducted by the AGA Institute, it was found out that non-alcoholic fatty liver disease (NAFLD) patients have a higher risk of developing a dangerous liver cancer called hepat
A:
Non-alcoholic fatty liver disease (NAFLD) is gradually becoming a global epidemic. The number of adults, and even children, being diagnosed with this silent killer skyrocketed like never before. Due to the broad spectrum of liver conditions that NAFLD includes (fatty liver and NASH), a recent research suggests that personalized risk prognosis and individualized treatment is needed in order to treat NAFLD more effectively.   Various health problems complicate t
Hit Questions
A:
The liver carries out essential functions, including detoxifying harmful substances in your body, cleaning your blood and making new blood and other vital nutrients. Cirrhosis is scarring of the liver caused by long-term liver damage. The loss of liver cells turns into scar tissue which prevents the liver working normally, reducing or in some cases, completely losing liver function. Cirrhosis is a long-term chronic liver damage; it is often caused by chronic live
A:
ALT (Alanine Aminotransferase / SGPT) is a type of enzyme found in liver cells. When the liver cells are functioning normally, the ALT enzymes should be contained within the liver cells.    You can imagine each liver cells as a balloon, and the ALT enzymes are the air inside the balloon. When the balloon is damaged, the air will be released. And when the liver cells is damaged, ALT enzymes are released into the bloodstream, therefore we are able to find out the l
A:
ALT (Alanine Aminotransferase / SGPT) is an enzyme that is mainly found in liver cells. The level of ALT in our bloodstream is the primary indicator of liver health.   What does high ALT indicate? ALT enzymes are normally contained within liver cells when the liver is healthy, but when the liver cells are injured or damaged by whatever means, ALT enzymes are released into the bloodstream, causing levels to go up. Therefore, by measuring the
A:
Fibrosis is scarring of the liver that results from chronic inflammation. It is a process where the damaged, dying liver cells are replaced by fibrous scar tissue, causing the liver to become hard. The extent of liver fibrosis can vary, and it is often classified in several stages. The most common classification is a scale from F0 to F4. F0 indicates no fibrosis. A normal liver is at a stage between F0 and F1. F2 denotes light fibrosis, and F3 indicates severe fibrosis. When scar tissue build
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us
Subscribe To Our Mailing List And
Never Miss Another Great Promotion!
Join our mailing list to receive latest new about our company, plus health articles. You will also be able to receive early bird discount from us!
Maybe Later, Thank you.
Subscribe success! You will receive latest new soon.